Loading...
Oncology Billing Services Billing & RCM Services
Qualigenix provides oncology billing services for medical oncology, hematology-oncology and radiation oncology practices: chemotherapy and infusion coding, regimen prior authorization, drug unit and modifier review, clinical trial billing, and drug payment reconciliation, delivered remotely to practices in 48 states. One missed drug unit or lapsed regimen authorization can cost an oncology practice more than weeks of visits. Qualigenix checks the infusion order, drug units and wastage reporting on every treatment day.
What Oncology Billing Demands
Oncology billing demands an approved authorization for every regimen, administration codes that follow the CMS infusion hierarchy, and drug lines with the right units and modifiers: JW or JZ for wastage on single-dose vials, and TB for 340B-acquired drugs. The drug line carries most of an oncology practice's revenue and most of its risk. Qualigenix checks all of it before the claim goes out. Book a free billing audit: 786-259-0231.
01
Chemo Administration Hierarchy
Chemotherapy and immunotherapy administration codes rank above therapeutic, prophylactic and hydration codes. When several drugs are given in one visit, the initial, sequential and concurrent codes depend on the drug type and documented start and stop times.
02
Regimen Prior Auth
Chemotherapy regimens, immunotherapy, oral oncolytics and high-cost supportive drugs almost always need prior authorization, often against pathway or NCCN-based criteria. A change in regimen usually needs a new approval.
03
J-Codes, Wastage and 340B
Each drug's HCPCS code has its own billing unit. Units must match the dose, single-dose vials need the JW or JZ modifier, and 340B-acquired Part B drugs need the TB modifier.
04
Clinical Trial Claims
Routine costs for patients in qualifying clinical trials are billable, but investigational items usually aren't. Medicare trial claims need the Q0 or Q1 modifier, the Z00.6 diagnosis code and the trial's registry number.
05
Medical vs Pharmacy Benefit
Infused drugs usually fall under the medical benefit and oral oncolytics under the pharmacy benefit. Checking the wrong benefit, or missing patient cost-share, delays treatment and creates uncollectable balances.
06
Regimen and Staging Records
Payers want the diagnosis, stage, regimen, cycle and response documented to support each drug. Infusion notes also need start and stop times.
07
Drug and Auth Denials
The costliest oncology denials come from lapsed authorizations, unit mismatches and regimens outside the payer's pathway. Checking the approval and the drug line before submission stops most of them.
08
Drug and Radiation Compliance
Part B drug claims are reviewed for unit accuracy and wastage reporting. In radiation oncology, IMRT delivery claims are an audit focus, so treatment plans and delivery records have to match what's billed.
PRECISION: WHAT QUALIGENIX DOES
How Qualigenix Protects Oncology Revenue
Qualigenix checks the drug line and the authorization first, where a single error costs the most.
Treatment-Day Coding
Our coders apply the CMS administration hierarchy to every treatment visit using documented start and stop times. Qualigenix holds 98.9% coding accuracy across all specialties it codes.
Regimen Auth Tracking
We request authorizations for each regimen and drug, track approval dates and cycle limits, and alert your team before an approval lapses or a regimen change needs a new one.
Unit and Modifier Review
Every drug line is checked for the right HCPCS code, units that match the dose, JW or JZ on single-dose vials, and TB on 340B drugs.
Trial Claim Setup
Clinical trial claims are set up with the Q0 or Q1 modifier, the Z00.6 diagnosis and the trial number, with routine costs separated from investigational items.
Benefit Verification
Each drug is checked against the patient's medical and pharmacy benefits, including cost-share, before the first cycle.
Documentation Support
Infusion and regimen records are checked for staging, cycle and timing details before the claim is sent.
Denials and Appeals
Off-pathway and auth denials are appealed with staging and treatment-plan records; unit and modifier errors are corrected and resubmitted. Qualigenix overturns 79% of the denials it works.
Compliance Monitoring
Drug and radiation claims are checked against wastage, 340B and payer drug-policy rules before submission.
Claims, Posting, AR and Reporting
Claims go out with an under 24-hour average submission turnaround, drug payments are posted line by line, and unpaid drug claims are worked first. Reports show drug margin by payer and by regimen.
CASE STUDY 01
How A Medical Oncology Practice Recovered $61K On Chemo-Admin & Wastage Errors
THE SITUATION
Chemotherapy administration was billed with multiple initial codes (96413) instead of a single initial plus add-ons (96415/96417), and single-use-vial drug wastage (e.g., J9299) was not reported with JW, so administration and high-cost drug claims denied.
WHAT QUALIGENIX DID
We enforced the chemo-admin hierarchy (96413 + 96415/96417), added JW/JZ wastage on single-dose vials, and reconciled J-code units to the regimen.
Key Outcomes & Turnaround
Audited Practice Results
How A Hematology-Oncology Group Recovered $94K On Drug-Billing Backlog
THE SITUATION
Buy-and-bill oncolytic claims aged after a billing gap, with unit and wastage reconciliation incomplete and a large unbilled balance.
WHAT QUALIGENIX DID
We cleared the backlog, reconciled J-code units and wastage to administration records, and set a daily drug-billing cadence.
Key Outcomes & Turnaround
Audited Practice Results
How An Infusion and Cancer Center Recovered $114K On Regimen Authorization Gaps
THE SITUATION
Chemotherapy and immunotherapy regimens proceeded before authorization, so the highest-dollar drug claims denied for missing auth.
WHAT QUALIGENIX DID
We added pre-service authorization and benefit verification for all regimens and tracked renewals across cycles.
Key Outcomes & Turnaround
Audited Practice Results
Oncology Coding From Infusion Chair to Treatment Plan
Chemo and Immunotherapy (96409, 96411, 96413, 96415, 96417)
IV push (96409, 96411) and IV infusion (96413, 96415, 96417) administration of chemotherapy and immunotherapy.
COMPLIANCE
How We Keep Oncology Billing Compliant
Qualigenix bills oncology claims within the rules that govern them: average-sales-price-based Medicare Part B drug payment, JW and JZ wastage reporting on single-dose containers, the TB modifier on 340B-acquired drugs, Medicare's clinical trial routine-cost rules, and radiation therapy documentation requirements. All work is HIPAA-compliant.
0%
Audit Pass Rate
<0%
Variance Threshold
Why Oncology Practices Choose Qualigenix
Oncology practices choose Qualigenix because it reviews every drug line for authorization, units and modifiers, where oncology dollars are concentrated.
0%
Coding accuracy
0%
First-pass clean claim rate on first submission
0%
Denials overturned on appeal
0%
Net collections rate
0days
Average onboarding time
QUESTIONS BUYERS ASK
Frequently Asked Questions
Qualigenix prices oncology billing after reviewing your infusion volume, drug mix and payer mix. A free billing audit gives you a quote and checks your drug lines for missed revenue. Call 786-259-0231 to start.
We add JW or JZ to every drug from a single-dose container, as CMS has required since July 1, 2023: JW for the amount discarded, JZ when none was. Multi-dose drugs don't carry either modifier.
We assign the initial service by CMS's hierarchy, with chemotherapy first, then therapeutic infusions, then hydration, and code the rest as sequential or concurrent based on documented start and stop times.
Yes. Qualigenix works aging drug and infusion claims first, since they carry the most dollars, correcting units and modifiers and appealing where the record supports payment. Most practices start with a free AR review.
We submit authorizations for each regimen and drug with the staging and treatment-plan details payers require, track approval dates and cycle limits, and request new approvals when the regimen changes.
Yes. Qualigenix bills routine costs for patients in qualifying trials with the Q0 or Q1 modifier, the Z00.6 diagnosis and the trial's registry number, and keeps investigational items off the claim unless the payer covers them.
Qualigenix works in 133 EMR and EHR platforms and bills from the system your practice already uses. We confirm access and workflow during onboarding.